[ET Net News Agency, 28 December 2021] InnoCare Pharma Limited (09969) said for the
three months ended 30 September 2021, the company has recorded sales of Orelabrutinib
amounting to approximately RMB73,972,900. (RC)
28/12/2021 09:49
InnoCare (09969) 3-month Orelabrutinib sales reach 73.97m
[ET Net News Agency, 28 December 2021] InnoCare Pharma Limited (09969) said for the
three months ended 30 September 2021, the company has recorded sales of Orelabrutinib
amounting to approximately RMB73,972,900. (RC)
Remark: | Real time quote last updated: 25/04/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |